Quantification of local de novo synthesis versus blood contributions to quinolinic acid concentrations in brain and systemic tissues

Journal of Neurochemistry

Volumn 68, Issue 1, 1997, Pages 280-288

  Heyes, Melvyn P ^a   Morrison, Paul F ^b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Blood brain barrier; Cerebral ischemic injury; Endotoxin; Kynurenine pathway; Mass spectrometry; Systemic immune activation

Indexed keywords

QUINOLINIC ACID; TRYPTOPHAN;

AMINO ACID BRAIN LEVEL; AMINO ACID SYNTHESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; CONTROLLED STUDY; GERBIL; HEART; KIDNEY; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; TISSUE DISTRIBUTION;

ANIMALIA; GERBILLINAE;

EID: 0031036955     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.68010280.x     Document Type: Article

References (33)

1. Achim C. L., Heyes M. P., and Wiley C. A. (1993) Quantitation of human immunodeficiency virus, quinolinic acid and immune activation factors in AIDS brains. J. Clin. Invest. 9, 2769-2775.
2. Achim C. L., Masliah E., Heyes M. P., Sarnacki P. G., Hilty C., Baldwin M., and Wiley C. A. (1996) Macrophage activation factors in the brains of AIDS patients. J. NeuroAIDS 1, 1-16.
3. Bender D. A. (1982) Biochemistry of tryptophan in health and disease. Mol. Aspects Med. 6, 101-197.
4. Blight A. R., Cohen T. I., Saito K., and Heyes M. P. (1995) Quinolinic acid accumulation and functional deficits following experimental spinal cord injury. Brain 118, 735-752.
5. Dedrick R. L. (1974) Animal scale up, in Pharmacology and Pharmacokinetics (Teorell T., Dedrick R. L., and Condliffe P., eds), pp 117-145. Plenum Press, New York.
6. Flanagan E. M., Erickson J. B., Viveros O. H., Chang S. Y., and Reinhard J. F. Jr. (1995) Neurotoxin quinolinic acid is selectively elevated in spinal cords of rats with experimental allergic encephalomyelitis. J. Neurochem. 64, 1192-1196.
7. Foster A. C., White R. J., and Schwarcz R. (1986) Synthesis of quinolinic acid by 3-hydroxyanthranilic acid oxygenase in rat brain tissue in vitro. J. Neurochem. 47, 23-30.
8. Fukui S., Schwarcz R., Rapoport S. I., Takada Y., and Smith Q. R. (1991) Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism. J. Neurochem. 56, 2007-2015.
9. 3H] kynurenine in the rat brain in vivo: evidence for the existence of a functional kynurenine pathway. J. Neurochem. 65, 2621-2632.
10. Heyes M. P. and Markey S. P. (1988) Quantification of quinolinic acid in rat brain, whole blood and plasma by gas chromatography and negative chemical ionization mass spectrometry: effects of systemic L-tryptophan administration on brain and blood quinolinic acid concentrations. Anal. Biochem. 174, 349-359.
11. Heyes M. P., Hutto B., and Markey S. P. (1988) 4-Chloro-3-hydroxyanthranilic acid inhibits 3-hydroxyanthranilic acid oxidase in brain. Neurochem. Int. 13, 405-409.
12. Heyes M. P., Quearry B. J., and Markey S. P. (1989) Systemic endotoxin increases L-tryptophan, 5-hydroxyindoleacetic acid, 3-hydroxykynurenine and quinolinic acid content of mouse cerebral cortex. Brain Res. 491, 173-179.
13. Heyes M. P., Pappagapiou M., Leonard C., Markey S. P., and Auer R. N. (1990) Brain and plasma quinolinic acid in profound insulin-induced hypoglycemia. J. Neurochem. 54, 1027-1033.
14. Heyes M. P., Brew B. J., Martin A., Price R. W., Salazar A. M., Sidtis J. J., Yergey J. A., Mouradian M. M., Sadler A. E., Keilp J., Rubinow D., and Markey S. P. (1991a) Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurologic status. Ann. Neurol. 29, 202-209.
15. Heyes M. P., Swartz K. J., Markey S. P., and Beal M. F. (1991b) Regional brain and cerebrospinal fluid quinolinic acid concentrations in Huntington's disease. Neurosci. Lett. 122, 265-269.
16. Heyes M. P., Jordan E. K., Lee K., Saito K., Frank J. A., Snoy P. J., Markey S. P., and Gravell M. (1992a) Relationship of neurologic status in macaques infected with the simian immunodeficiency virus to cerebrospinal fluid and serum quinolinic acid and kynurenic acid. Brain Res. 570, 237-250.
17. Heyes M. P., Saito K., Crowley J., Davis L. E., Demitrak M. A., Der M., Dilling L., Kruesi M. J. P., Lackner A., Larsen S. A., Lee K., Leonard H., Markey S. P., Martin A., Milstien S., Mouradian M. M., Pranzatelli M. R., Quearry B. J., Salazar A., Smith M., Straus S. E., Sunderland T., Swedo S., and Tourtellotte W. W. (1992b) Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurologic disease. Brain 115, 1249-1273.
18. Heyes M. P., Saito K., Jacobowitz D., Takikawa O., Markey S. P., and Vickers J. (1992c) Poliovirus induces indoleamine-2,3-dioxygenase and quinolinic acid synthesis in macaque brain. FASEB J. 6, 2977-2989.
19. Heyes M. P., Saito K., Major E. O., Milstien S., Markey S. P., and Vickers J. H. (1993) A mechanism of quinolinic acid formation by brain in inflammatory neurologic disease: attenuation of synthesis from L-tryptophan by 6-chloro-tryptophan and 4-chloro-3-hydroxyanthranilate. Brain 116, 1425-1450.
20. Heyes M. P., Achim C., Wiley C. A., Major E. O., Saito K., and Markey S. P. (1996) Human microglia convert L-tryptophan to the neurotoxin quinolinic acid. Biochem. J. (in press).
21. Jobin J. and Bonjour J.-P. (1985) Measurement of glomerular filtration rate in conscious unrestrained rats with insulin infused by implanted osmotic pumps. Am. J. Physiol. (Renal Fluid Electrolyte Physiol. 17) 248, F734-F738.
22. Langsdorf L. J. and Zydney A. L. (1991) Red blood cell membrane permeability of uremic and normal cells. ASAIO Trans. 37, M461-M462.
23. Okuno E. and Kido R. (1991) Kynureninase and kynurenine-3-hydroxylase in mammalian tissues, in Kynurenine and Serotonin Pathways (Schwarcz R., Young S. N., and Brown R. R., eds) pp. 167-176. Plenum Press, New York.
24. Saito K., Markey S. P., and Heyes M. P. (1992) Effects of immune activation on quinolinic acid and kynurenine pathway metabolism in the mouse. Neuroscience 51, 25-39.
25. Saito K., Chen C. Y., Masana M., Crowley J., Markey S. P., and Heyes M. P. (1993a) 4-Chloro-3-nydroxyanthranilic acid, 6-chlorotryptophan and norharmane attenuate quinolinic acid formation by interferon-γ stimulated monocyte (THP-1) cells. Biochem. J. 291, 11-14.
26. Saito K., Crowley J. S., Markey S. P., and Heyes M. P. (1993b) A mechanism for increased quinolinic acid formation following acute systemic immune stimulation. J. Biol. Chem. 268, 15496-15503.
27. Saito K., Nowak T. S. Jr., Markey S. P., and Heyes M. P. (1993c) Mechanism of delayed increases in kynurenine pathway metabolism in damaged brain regions following transient cerebral ischemia. J. Neurochem. 60, 180-192.
28. Saito K., Nowak T. S., Suyama K., Quearry B. J., Saito M., Crowley J. S., Markey S. P., and Heyes M. P. (1993d) Kynurenine pathway enzymes in brain: responses to ischemic brain injury versus systemic immune activation. J. Neurochem. 61, 2061-2070.
29. Saito K., Quearry B. J., Saito M., Nowak T. S., Markey S. P., and Heyes M. P. (1993e) Kynurenine-3-hydroxylase in brain: species activity differences and effect of gerbil cerebral ischemia. Arch. Biochem. Biophys. 307, 104-109.
30. Speciale C., Ungerstedt U., and Schwarcz R. (1989) Production of extracellular quinolinic acid in the striatum studied by microdialysis in unanesthetized rats. Neurosci. Lett. 104, 345-350.
31. Stone T. W. (1993) Neuropharmacology of quinolinic and kynurenic acids. Pharmacol. Rev. 45, 309-379.
32. Takikawa O., Yoshida R., Kido R., and Hayaishi O. (1986) Tryptophan degradation in mice initiated by indoleamine-2,3-dioxygenase. J. Biol. Chem. 261, 3648-3653.
33. Vogelgesang S. A., Heyes M. P., West S. G., Salazar A. M., Sfikakis P. P., Lipnick R. N., Klipple G. L., and Tsokos G. C. (1996) Quinolinic acid in patients with systemic lupus erythematosus and neuropsychiatric manifestations. J. Rheumatol. 23, 850-855.